Yüklüyor......
Anti-programmed cell death protein-1/ligand-1 therapy in different cancers
Immunologic checkpoint blockade with antibodies against the programmed cell death protein-1 (PD-1) or its ligand (PD-L1) is an effective method for reversing cancer immunosuppression and thereby promoting immune responses against several cancer types. Anti-PD-1 and anti-PD-L1 antibodies have resulte...
Kaydedildi:
| Yayımlandı: | Br J Cancer |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4453674/ https://ncbi.nlm.nih.gov/pubmed/25856776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.124 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|